COVID-19 Pandemic – A Paediatric Perspective

  • Riaz I Government Medical College, Thiruvananthapuram
  • Reshma Raj SAT Hospital, Govt Medical College, Thiruvananthapuram
Keywords: SARS CoV 2, COVID-19, Children, pediatric, Asymptomatic

Abstract

SARS CoV-2, the virus responsible for the current pandemic COVID-19 has resulted in 4.2 million cases and 2.9 lakhs deaths globally by mid- May 2020. Children are less likely to be symptomatic or develop severe symptoms with SARS-CoV-2 infection. Recent US reports show that rate of hospitalization is less in children (5.7%) when compared to adults (10%). Most common presenting complaints include fever, cough and sore throat; eight cases of Kawasaki disease/toxic shock syndrome like presentation with multi organ dysfunction has also been published from UK. For management, clinical categorization as A, B and C is helpful. Patients with comorbidities, on immunosuppressants, severe respiratory symptoms, altered sensorium and shock need hospitalization, close monitoring and care. Mainstay of diagnosis is with RT-PCR of nasopharyngeal swab. Treatment includes supportive care for category A, Hydroxychloroquine and Azithromycin for category B and C. In addition, if there is clinical worsening, Lopinavir/Ritonavir, Remdesivir (not available in India) and Tocilizumab may be considered. Appropriate protective gears and reduction of aerosol generating procedures are effective infection control strategies.

Author Biographies

Riaz I, Government Medical College, Thiruvananthapuram

Associate Professor, Department of Pediatrics, SAT Hospital

Reshma Raj, SAT Hospital, Govt Medical College, Thiruvananthapuram

Junior Resident, Department of Pediatrics

Published
2020-05-22